HLRCC is a rare autosomal dominant syndrome characterized by a predisposition to smooth muscle tumors and aggressive kidney cancer, driven by germline mutations in the FH gene, consisting of heterozygous germline FH mutations at chromosome 1q42.3-q43 [4]. The gene discussed is FH; the disease is smooth muscle tumor.